Globus Medical has entered into a definitive agreement to acquire all shares of Nevro Corp. in an all-cash transaction. The transaction is expected to close late in the second quarter of 2025.
Under the terms of the agreement, which was unanimously approved by the boards of directors of both companies, Globus Medical will acquire all shares of Nevro for $5.85 per share. The transaction represents a total equity value of approximately $250 million.
Nevro Corp. is a global medical device company that is delivering comprehensive solutions for the treatment of chronic pain. The company is headquartered in Redwood City, California. According to its fourth-quarter and full-year 2023 financial results, Nevro’s full-year (FY) 2023 worldwide revenue was $425.2 million, and its FY 2023 adjusted EBITDA was a loss of $17.7 million.
Globus Medical is a medical device company headquartered in Audubon, Pennsylvania. The company designs, develops and commercializes musculoskeletal implants. According to its most recent annual report, Globus Medical’s revenue during FY 2023 was $1.6 billion.
According to data in the LevinPro HC database, this merger marks the 12th Medical Devices transaction of 2025. There were 88 Medical Devices acquisitions announced in 2024, 112 announced in 2023 and 124 announced in 2022. In February 2023, Globus Medical merged with NuVasive, a medical device company based in San Diego, in a $3.1 billion deal.
